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Abstract.  Five intestinal defensins, termed cryptdins 
1-5,  have been purified from mouse smaU bowel, se- 
quenced,  and localized to the epithelium by immuno- 
histochemistry.  Although identified as members of the 
defensin peptide family by peptide sequencing,  enteric 
defensins are novel in that four cryptdins have amino 
termini which are three to six residues longer than 
those of leukocyte-derived defensins.  A fifth cryptdin 
is the first defensin to diverge from the previously in- 
variant spacing of cysteines in the peptide structure. 
The most abundant enteric defensin, cryptdin-1, had 
antimicrobial activity against an attenuated phoP mu- 
tant of Salmonella  typhimurium  but was not active 
against the virulent wild-type parent.  Immunohisto- 
chemical localization demonstrated that cryptdin-1, and 
probably cryptdins 2 and 3, occur exclusively in Paneth 
cells, where the peptides appear to be associated with 
cytoplasmic granules.  Biochemical and immunologic 
analysis of the luminal contents of the small intestine 
suggest that cryptdin peptides are secreted into the lu- 
men,  similar to Paneth cell secretion of lysozyme. The 
presence of several enteric defensins in the intestinal 
epithelium,  evidence of their presence in the lumen, 
and the antibacterial  activity of cryptdin-1  suggest that 
these peptides contribute to the antimicrobial  barrier 
function of the small bowel mucosa. 
D 
FENSINS are highly abundant  antimicrobial  peptide 
components of  vertebrate neutrophil and macrophage 
granules (Lehrer et al., 1991a). These cationic  3-4 
kD  peptides  exhibit  broad-range  antimicrobial  activities 
against  gram  negative  and  gram  positive bacteria,  many 
fungi, and some enveloped viruses (Ganz et al., 1990). Evi- 
dence suggests that defensins  exert their antibacterial  effect 
by permeabilizing  the cytoplasmic membrane of the target 
microorganism (Lehrer et al.,  1989) by a mechanism that 
may involve  the formation of ion channels  (Kagan et al., 
1990; Hill et al., 1991). Members of the defensin family have 
been identified previously in human, rabbit, guinea pig, and 
rat phagocytes (Lehrer et al., 1991a). The peptides are char- 
acterized by nine highly  conserved amino acids,  including 
six invariant cysteine residues which constitute  a unique di- 
sulfide motif (Fig.  1; Selsted and Harwig, 1989). The three 
disulfides  stabilize a tertiary conformation consisting  pre- 
dominantly  of beta-sheet (Pardi  et al.,  1988;  Hill et al., 
1991). The highly ordered structure and the absence of helix 
make defensins unique among known antimicrobial  peptides. 
A role for defensin peptides in enteric host defense was 
suggested  by  the  identification  of  an  mRNA  that  was 
predicted to code for a defensin in Paneth cells of the mouse 
small  intestine  (Ouellette et al.,  1989a).  Paneth  cells  are 
granulated  epithelial cells that reside at the base of intestinal 
crypts (Madara and Trier,  1987), and they derive from stem 
cells  that  also produce villus  enterocytes (Cheng  et  al., 
1969).  In contrast to short-lived  enterocytes which ascend 
the villus and exfoliate into the lumen within 2-3 d, Paneth 
cells mature below the proliferative  zone and have apparent 
lifetimes of ~ 20 d (Troughton and Trier, 1969). Paneth cells 
synthesize proteins generally considered to be characteris- 
tic  of leukocytes, including  tumor  necrosis factor  (TNF) 
(Keshav et al., 1990) and lysozyme (Speece, 1964; Hammer 
et al., 1987). Since lysozyme may be secreted into the lumen 
of  the small bowel under cholinergic  stimulation (Peeters and 
Vantrappen,  1975),  these cells may secrete additional  an- 
timicrobial  factors,  thereby restricting  the colonization  and 
invasion of the epithelium  by bacteria. 
An intestinal  defensin  mRNA, termed cryptdin mRNA, 
was detected exclusively in Paneth cells of the small bowel 
(Ouellette et al., 1989a).  Cryptdin mRNA is one of several 
highly  abundant  low  molecular weight intestinal  mRNAs 
which code for small,  cysteine-rich  polypeptides that  ac- 
cumulate in mouse small bowel during its postnatal matura- 
tion  (Ouellette  and  Cordell,  1988;  Ouellette and Lualdi, 
1990). Mouse cryptdin mRNA is predicted to code for a 93 
amino acid protein that is similar to the deduced human and 
rabbit neutrophil  defensin precursors (Daher et al.,  1988; 
Ganz et al., 1989). The cryptdin gene, Defcr, in the proximal 
region of chromosome 8, shows conserved linkage homology 
with the human defensin gene(s) DEFI on 8p23  (Ouellette 
et al., 1989b; Sparkes et al., 1989). By homology with leu- 
kocyte defensins, processing of the deduced cryptdin precur- 
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Figure 1.  The covalent consensus structure of myeloid defensins. 
Residues which are invariant in 13 of 16 defensin peptides purified 
from neutrophils and macrophages are shown in single letter code. 
Residues which vary between defensins are shown as "x" charac- 
ters;  the "a" character  represents 0-2  NH2-terminal  amino  acid 
residues;  the  "b" character  denotes  0-3  COOH-terminal  amino 
acids. The disulfide bonding motif is depicted by connecting double 
lines. 
sor was predicted to produce a peptide of  30-32 residues, de- 
pending  upon  the  site  of amino-terminal processing.  To 
determine the actual cryptdin peptide sequence and to test 
for antibacterial activity, we isolated the predicted molecule. 
Here, we report the purification and sequencing of five en- 
teric defensins, including cryptdin-1, the peptide predicted 
by the cryptdin cDNA sequence. In addition, we present data 
that demonstrate the antibacterial activity of the most abun- 
dant enteric defensin, immunohistochemical localization of 
one  or  more  enteric  defensins to  Paneth  ceils,  and  im- 
munochemical  and  biochemical  evidence  suggestive  of 
secretion of defensins into the lumen of the small bowel. 
Materials and Methods 
Animals and ~ssue Preparation 
Outhred Swiss mice [(Crl:CD-1)(ICR)BR],  45-d-old males (30-35 g) or 
timed-pregnant  dams, were obtained from Charles River Breeding Labora- 
tories, Inc. (North Wilmington, MA). Mice were housed under 12-h cycles 
of light and darkness and had free access to food and water. Jejunum and 
ileum were removed en bloc from mice killed by cervical dislocation.  The 
lumen of each resected intestine was rinsed with 35 ml PBS, and the wash 
was acidified by addition of 3.5 ml glacial acetic acid and frozen.  Washed 
intestines from individual mice were disrupted thoroughly in 35-ml ice-cold 
30% formic acid using a Polytron homogenizer (Brinkmann Instruments, 
Westbury,  NY).  Homogenates were stirred continuously  for 18 h at 4"C, 
clarified by centrifugation at 27,000 rpm in the SW28.1 rotor for 30 min at 
4~  lyophilized,  and stored at -85~ 
Sheets of intestinal epithelium were isolated by EI~A perfusion (Bjerk- 
nes and Cheng, 1981). After irrigation of the intestinal lumen, anesthetized 
mice were perfused systemically  with 30 mM EDTA in Ca++/Mg++-free 
HBSS by left ventricular injection.  Epithelial sheets were separated from 
basement membrane of the underlying lamina propria by gentle shaking of 
the everted intestine in ice-cold Mg++-free Hanks buffer. Under these con- 
ditions,  sheets of intestinal epithelium were released from the lamina pro- 
pria and then sedimented by eentrifugation.  The pelleted cells were then ho- 
mogenized as before in 10 ml of 30% formic acid. 
Purification of Enteric Defensins 
Lyophilized  acid extracts  were dissolved  in 100 ml of 30% acetic acid, 
stirred for 2  h  at room temperature,  and clarified  by centrifugation at 
27,000 g at 22~  for 1 h. The supernatant was concentrated to 30 ml by 
centrifngal evaporation and chromatographed (15 ml per loading) on a 2.5 
x  55 cm column of Bio-Gel P-60 equilibrated in 30% acetic acid. 7.5-m1 
fractions were collected at 15 ml/h while the effluent was continuously 
monitored at 280 rim. A 200-V.1 sample of each fraction was lyophilized, 
dissolved in 30 #t of 5% acetic acid containing 3.0 M urea, and electropho- 
resed on 12.5 % acid-urea acrylamide gels (selsted and Harwig,  1987). Pro- 
tein bands were visualized with Coomassie R-250. 
Fractions containing putative defensins  were  identified  by acid-urea 
PAGE, in which the peptides  migrated rapidly (>0.6  x  Rf of the methyl 
green tracking dye) and by SDS-PAGE where the peptides had apparent 
M/s of 4. These fractions were pooled, lyophllized,  and dissolved in 6 ml 
of 30% acetic acid and rechromatographed on Bio-Oel P-60. Final purifica- 
tion of five enteric defensins was achieved by RP-HPLC  on a 0.46  x  25 
cm Vydac C-18 column using HFBA and TFA as ion-pairing agents as de- 
scribed in Results. 
Peptide Characterization 
Amino acid analyses were performed on 6 N HC1 hydrolysates (150"(2, 2 h) 
of unmodified  or performic-acid oxidized peptides.  Hydrolysates  were 
derivatized with phenylisothiocyanate,  and the resulting  phenythiocarbamyl 
amino acids were quantitated as described previously (selsted and Haswig, 
1987). Peptide samples were reduced with DTT and pyridyl  ~ethylated with 
4-vinylpyridine for sequencing (Henschen, 1986). Sequence determinations 
were performed by automated Edman degradation on an ABI model 477 
system  (Applied  Biosystems,  Inc.,  Foster City,  CA) with on-line PTH 
amino acid analysis.  In certain cases, the COOH terminus was confirmed 
by amino acid analysis of tryptic peptides. 
Antimicrobial Assay 
Antibacterial activity was measured in an agar diffusion assay (Lehrer et 
al.,  1991b) using wild-type Salmonella typhimurium (ATCC10428) or an 
isogenic phoP mutant of S. typhimurium (strain CS015 phoP102::Tni0d- 
Cam; Miller et al., 1989). ATCC10428 and CS015 were grown to log phase 
in trypticase soy broth at 370C, harvested by centrifugation, and resus- 
pended to 1 ￿  107 colony forming units (CFU) per ml in 10 mM sodium 
phosphate buffer (pH 7.4). A  100-/zl aliquot of each organism was mixed 
with 10 mi of 1% agarose in 0.03 % (wt/vol) trypticase soy medium, 10 mM 
sodium phosphate (pH 7.4) at 420C. 5-/~1  samples of peptide solution were 
pipetted into 3-ram diameter wells formed  in the ngarose with a  sterile 
punch. After 3 h at 370C, the inoculated ngarose plate was overlaid with 
1% agarose containing 6% trypticase soy medium. After 12-16 h, antimi- 
crobial activity was apparent as clear zones surrounding wells loaded with 
antibacterial samples. 
Anticryptdin Antibody 
A  polyclonal  rabbit antibody was  prepared to  a  synthetic analogue of 
cryptdin-1.  The peptide,  cryptdin-C,  corresponding to residues 4-35 in 
cryptdin-1 (see Fig. 4) was synthesized by solid phase chemistry using N a- 
butoxycarbonyl  protection (Kent,  1988).  After cleavageJdeprotection  of 
synthetic cryptdin-C with TFA-trifluoromethanesulfonic  acid, the peptide 
was precipitated in ethyl ether and dried in vacuo. A  100-rag sample was 
dissolved in 10 ml of 6.0 M guanidine-HCl, 0.2 M Tris-HC1, pH 8.2, con- 
taining 20 mg of DTT. The sample  was purged with nitrogen, heated to 
50~  for 4 h, diluted  100-fold with deionized water, and dialyzed exhaus- 
tively, first against 0.1 M sodium phosphate (pH  8.2), 20 mM guanidine- 
HC1, 100 mM NaCI, then against 5% acetic acid. The sample was lyophi- 
lized, dissolved in 10 ml 5 % acetic acid, and subjected to RP-HPLC  on a 
1  x  25 cm Vydac C-18 column. The earliest eluting peak, representing 
-,~0.5 % of the crude peptide was determined by amino acid analysis to have 
the desired composition. 
A 1.5-mg sample ofcryptdin-C was supplied to Berkeley Antibody Com- 
pany (Berkeley, CA) for immunization of two New Zealand White rabbits. 
Serum samples were collected for 12 wk, until the anticryptdin C filer, de- 
termined by ELISA,  reached ,o1:10,000 for each rabbit. IgG was isolated 
from antiserum using DEAE Econo-Pac chromatography (Bio-Rad Labora- 
tories, Richmond, CA) as described by the manufacturer. 
Immunohistochemistry 
Paraffin sections  of formalin-fixed  mouse mid small bowel were deparaf- 
finized, treated with 1.1% hydrogen peroxide for 40 min, washed extensively 
with water and then with PBS. Slides were treated for 20 rain at 370C with 
500 ~g/ml trypsin in PBS, washed twice with PBS, and blocked for 20 min 
with 5 % porcine serum. Slides were incubated for 20 rain in rabbit anti- 
cryptdin IgG  (1:10 dilution relative to  serum  IgG  concentration), and 
washed with blocking serum. Porcine anti-rabbit IgG was used as linkln~ 
reagent between the primary antibody and rabbit  antiperoxidase-peroxidase 
conjugate (Dako, Carpenteria, CA). DAB was used as peroxidase substrate, 
and parallel incubations  were performed using equivalent  dilutions  of rabbit 
preimmune IgG as the primary antibody. 
Results 
Purification of  Enteric Defensins 
Initial efforts to purify intestinal defensins focused on the iso- 
lation of cryptdin-1, the peptide predicted from the cryptdin 
eDNA sequence.  Since the deduced peptide is highly cat- 
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Figure 2. Purification of enteric defensins. Acid extract of  jejunum 
and ileum was chmmatographed in 30% acetic acid on a P-60 col- 
tram. Fractions indicated by brackets (A) were pooled and rechro- 
matographed  on the P-60 column (B).  Defensin-containing frac- 
tions (brackets, B) were pooled and further purified by RP-HPLC 
on a 0.46 x 25 cm Vydac  C-18 column. Water-acetonitrile gradient 
elution (dashed line) using 0.13 % (vol/vol) HFBA as modifier was 
used to purify cryptdins 1-5. The brackets in C indicate the peptide 
contained  in each peak,  and the portion of each which was sub- 
jected to a second round of RP-HPLC. 
ionic, intestinal peptides were solubilized by homogenizing 
intact jejunum  and  ileum  in  30%  formic acid.  Acid-urea 
PAGE of the crude extract revealed several bands with Re 
values similar to those of rabbit defensin NP-1 and cryptdin- 
C  (data not shown),  a  folded synthetic defensin congener 
corresponding to residues 4-35 in cryptdin-1 (Material and 
Methods).  Peptides  corresponding  to  these  bands  were 
purified ,,o200-fold by two rounds of gel filtration chroma- 
tography on Bio-Gel P-60 (Fig. 2, upper and middle). Elec- 
trophoresis of P-60 column fraction samples on acid-urea 
gels  showed that five fractions which eluted between two 
prominent peaks (Fig. 2, A and B, brackets) contained puta- 
tive cryptdin peptides (Fig. 3, lane a). Peptides in these P-60 
fractions migrated with M,'s of "~4 on SDS-PAGE (data not 
shown), consistent with the molecular weight of defensins. 
Furthermore, treatment of P-60 fraction samples with per- 
formic acid markedly reduced the electrophoretic mobility 
of the  five putative  cryptdins  in  acid-urea  gels  (data  not 
shown), behavior that is characteristic of defensins and poly- 
peptides that contain multiple cysteine residues. 
Defensins in pooled P-60 fractions were purified further 
using sequential rounds of RP-HPLC utilizing different ion- 
pair agents. Initial HPLC fractionation utilized water-acetoni- 
Figure 3.  Acid urea PAGE of 
enteric defensins. Samples of 
low molecular weight enteric 
peptides obtained by P-60 gel 
filtration (Fig. 2, B, brackets) 
and  purified  cryptdins  were 
electrophoresed  on a  12.5% 
acid-urea gel, and stained with 
formalin-containing Coomas- 
sic  blue. (Lane  A)  ",20  #g 
P-60  low  molecular  weight 
peptide fraction;  (B-F) 1 #g 
each of cryptdins 1-5, respec- 
tively. 
trile  gradients  containing  0.13%  heptafluorobutyric acid 
(HFBA) as the ion-pairing agent, whereby each of the five 
peptides contained in the pooled P-60 fractions was resolved 
to near purity in a single run (Fig. 2, bottom). Complete pu- 
rification of five peptides,  cryptdins  1-5,  was  achieved by 
subsequent RP-HPLC using 0.1% trifluoroacetic acid (TFA) 
(Fig. 3, lanes b-f).  Assuming that extraction of individual 
peptides was  equally  efficient, both acid-urea gel electro- 
phoresis and RP-HPLC of the P-60 fractions containing pu- 
tative cryptdins showed that the relative abundance of the 
peptides is cryptdin-1 > cryptdin-2 > cryptdin-5 > cryptdin- 
3 >  cryptdin-4. These relative amounts have been qualita- 
tively reproducible in  every preparation of acid-extracted 
protein from mouse small intestine. We have not established 
whether differences in cryptdin levels results from variation 
between individual crypts, between individual mice, or dif- 
ferential levels of individual cryptdins along the length of the 
bowel. 
Characterization  of C ryptdins 1-5 
Biochemical characterization of cryptdins 1-5 demonstrated 
that these peptides are defensins.  Amino acid analysis of 
each peptide showed that their compositions were compati- 
ble with defensin-like molecules: cationic peptides of 31-35 
residues which included 6 half-cystines (Table I). The com- 
plete sequences of cryptdins 1-5 were determined by auto- 
mated  degradation  and  amino  acid  analysis  of carboxyl- 
terminal tryptic peptides. As shown in Fig. 4,  the primary 
structures of the five enteric defensins contain the distinctive 
structural features of human, rabbit, rat, and guinea pig neu- 
trophil defensins (Lehrer et al., 1991a), i.e., the six invariant 
cysteine residues, and glycine and glutamic acid in positions 
that are also highly conserved in myeloid defensins. 
Cryptdins 1-5 contain features that are unique and distinct 
from defensins of myeloid origin. Cryptdin-1 is the peptide 
predicted by the cryptdin cDNA sequence, and it is almost 
identical to cryptdins 2 and 3, differing in sequence only at 
position 10 (Ser, Thr, or Lys), position 15 (Gly or Arg), or 
position 29 (Leu or Met) as shown in Fig. 4.  Analysis of 
codons from which these amino acid differences could arise 
shows that the conversion of Ser  t~ to Lys  1~ in  cryptdins  1 
and 3, respectively, requires two nucleotide substitutions. On 
the other hand, single nucleotide changes in cryptdin-2 could 
give  rise  both  to  cryptdins  1  and  3,  suggesting  that  the 
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Residue  Cryptdin-I  Cryptdin-2  Cryptdin-3  Cryptdin-4  Cryptdin-5 
Cysteine  5,22  [6]  5.29  [6]  5,86 [6]  6.60 [6]  5.90 [6] 
Aspartic acid  1.74 [2]  1.72 [2]  1.88 [2]  0  1.35 [ll 
Glutamic acid  1.31 [1]  1.01 [1]  1.03 [1]  1.37 [1]  1.40 [1] 
Serine  0.84  [1]  0  0  0  1.31 [1] 
Glycine  4.28  [4]  2.73  [3]  2.92  [3]  4.80 [5]  2.09  [2] 
Histidine  0.67 [1]  0.90 [1]  0.88 [1]  0.99 [1]  0 
Arginine  7.04 [7]  7,76 [8]  8.35  [8]  5,98  [6]  6.16  [6] 
Threonine  2.06 [2]  2,40 [3]  1.96 [2]  1,25 [1]  1.68 [2] 
Alanine  0  0  0  0  0 
Proline  0  0  0  0.87  [1]  0 
Tyrosine  1.90 [2]  1.81 [2]  1.73 [2]  1.94 [2]  1.04 [1] 
Valine  0.96  [1]  0.88  [1]  0.95  [1]  1.05 [1]  2.02  [2] 
Methionine  0.62 [1]  1,78 [2]  1,68 [2]  0  0 
Isoleucine  0  0  0  0.88 [1]  1.91 [2] 
Leucine  4.10 [5]  4,50 [5]  4.21  [4]  3.21  [3]  3,77  [4] 
Phenylalanine  0  0  0  0.85  [1]  3.63  [4] 
Tryptophan  0  0  0  0  0 
Lysine  1.97 [2]  2.07  [2]  2.83  [3]  2.12  [2]  2.87  [3] 
Total  35  35  35  31  35 
Brackets denote residue numbers determined by sequence analysis. 
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cryptdin-2 gene may be an intermediate or progenitor of the 
cryptdinq  and cryptdin-3 genes. 
By homology with the structures of known myeloid defen- 
sins, the cryptdin-1 NH2 terminus had been predicted to be 
at  Leu  4 or VaP,  1  or 2  residues  before  the  first  cysteine. 
However, compared to myeloid defensins,  intestinal defen- 
sins have variably extended NH~ termini that contain from 
three (cryptdin-4) to six (cryptdin-5) amino acids preceding 
the first cysteine. In cryptdins 1-3 and 5, the N-peptidyl ex- 
tensions consist of two charged internal residues flanked by 
amino acids with hydrophobic sidechains. Since natural vari- 
ation in defensin amino termini has been shown to correlate 
with  relative  antimicrobial  potency  in vitro  (Ganz et  al., 
1985),  we speculate that the extended NH2 termini  of en- 
teric  defensins  may have  evolved for a  unique  role in the 
bowel or that the peptides undergo further processing at the 
amino terminus. 
Cryptdin-4, the most cathodal (and apparently least abun- 
dant) enteric defensin is the first defensin found to contain 
a chain length variation between the fourth and fifth cysteine 
residues.  Unlike all known defensins  in which nine amino 
acids separate the fourth and fifth cysteines (Lehrer et al., 
1991a),  cryptdin-4 contains only six  residues  between the 
same two amino acids. This finding reveals that the defensin 
fold involving this stretch of the pepfide chain can accommo- 
date  a  substantially  smaller  loop  than  the one defined  by 
crystal and NMR structures, respectively, of  human and rab- 
bit neutrophil defensins (Hill et al., 1991; Pardi et al.,  1988). 
b'igure  5. Identification of  crypt- 
dins 1-5 in small intestinal ep- 
ithelium.  Acid extracts  of in- 
tact,  whole  small  intestine 
(W) or epithelial  sheets were 
lyophilized,  dissolved in sam- 
ple solution and resolved on a 
12.5%  acid-urea  acrylamide 
gel.  Cryptdins 1-5 are identi- 
fied numerically. 
The Journal of Cell Biology, Volume 118, 1992  932 Figure 6. Immunohistochemical  localization  of  cryptdin-1 in small intestine. Full thickness sections of adult mouse jejunem were incubated 
with preimmune (A, C, E) or anti-cryptdin-C rabbit IgG (B, D, F) and developed using peroxidase-antiperoxidase  secondary antibody. 
Original magnifications: A and B, 40X; C and D, 250X; E and E  640X. 
Cryptdins 1-5 Are Epithelial Defensins 
Cryptdins 1-5 derive from intestinal epithelial cells. In the 
presence of EDTA, the intestinal epithelium no longer ad- 
heres to the underlying basement membrane and floats free 
of the lamina propria upon gentle agitation (Bjerknes and 
Cheng,  1981). Preparations of epithelial sheets isolated in 
this manner (Materials and Methods) were concentrated by 
low-speed centrifugation and extracted  with  30%  formic 
acid. Peptides extracted from isolated epithelial sheets co- 
migrated with cryptdins  1-5  when analyzed by acid-urea 
PAGE (Fig.  5), demonstrating their epithelial origin. 
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dins 1-5 and partially purified 
luminal peptides. (.4) Lyophil- 
ized luminal lavage of small 
intestine from  12  mice  was 
fractionated  by P-60 gel filtra- 
tion (Materials and Methods) 
and electraphoresed  on an  acid- 
urea acrylamide gel (20 #g; 
lane 2) along side a similarly 
prepared sample of bowel tis- 
sue extract (20  ~g; lane 1). 
The positions of cryptdins 1-5 
are  indicated; (B)  Partially 
purified luminal peptides (20 
#g; same material as in lane 2) 
was electrophoresed in a second acid-urea gel (lane 3) along with 
an identical sample which had been previously treated with perfor- 
mic acid (lane 4). In lane  4, rapidly migrating, cyst(e)ine-containing 
peptides are absent due to the increased net negative  charge result- 
ing from the conversion of cyst(e)ines to cysteic acid residues. 
Immunohistochemical Localization  of  Cryptdin-1 in 
Small Bowel 
Immunoperoxidase  staining  of full-thickness  sections  of 
small intestine with an anticryptdin antibody demonstrated 
cryptdin antigen in Paneth cells, consistent with localization 
of cryptdin mRNA by in sire hybridization (Ouellette et al., 
1989a). Incubation of sections of adult mouse jejunum and 
ileum with a polyclonal anti-cryptdin IgG produced by rab- 
bits  immunized  with  the  synthetic  congener  cryptdin-C 
(Materials and Methods) localized the immunoperoxidase 
reaction  to  granulated  cells,  morphologically defined as 
Paneth cells, at the base of every crypt (Fig. 6). The staining 
pattern  accentuates the  granular  appearance  of the cyto- 
plasm in these cells, and the immunoreactivity appears to be 
particularly strong over Paneth cell granules. The antibody 
is specific for mouse cryptdin(s), since it is negative both for 
rat and human Paneth cells (data not shown). Leukocytes in 
the lamina propria of the villi also were negative, suggesting 
that related enteric defensins are not expressed by phagocytes 
or lymphocytes. Because of  the extensive similarity of  crypt- 
dins I-3 (Fig. 4), the polyclonal antibody produced against 
cryptdin-C probably  recognizes the  three  peptides.  Con- 
versely, because crypldins 4  and 5  differ markedly from 
cryptdins 1-3, the anti-cryptdin-C antibody is unlikely to re- 
act with cryptdins 4 and 5 leaving their origin in Paneth cells 
somewhat unresolved. 
Cryptdins in the Intestinal Lumen 
Immunohistochemical and biochemical data  suggest that 
cryptdins are present in the intestinal lumen. In each of sev- 
eral independently processed full section preparations, ma- 
terial in the small intestinal lumen was strongly immunoper- 
oxidase-positive with anti-cryptdin-C antibody, but negative 
for preimmune sera or IgG. The reproducible pattern of im- 
munoreactivity in the lumen is well represented by the pho- 
tomicrographs in Figs. 6 (.4 and B). Consistent with immu- 
nochemical detection of anti-cryptdin-C positive material in 
the intestinal lumen, peptides in saline washes of adult je- 
junum and ileum eluted from the P-60 column at the same 
elution volume as cryptdins 1-5 and in acid-urea PAGE have 
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Figure 8. Antimicrobial  activ- 
ity of mouse cryptdin-l. Sam- 
pies of rabbit NP-1 or purified 
natural cryptdin-I dissolved  in 
0.01% acetic acid were pipet- 
ted into wells produced in a 
0.6% agarose/0.3% tryptone 
plate containing 1 x  106 log 
phase cells. After incubation 
at 37"C for 18 h, antimicmbial 
activity was evaluated  by mea- 
surement of the diameters of 
the clear zones. Closed circles 
denote wild-type S. typhimu- 
rium; open circles denote the 
phoP mutant. 
mobilities  similar to  those of cryptdins  1-4.  (Fig.  7  A). 
Though the lavage peptides are not identical to the charac- 
terized cryptdins in acid-urea PAGE (Fig. 7 A) or RP-HPLC 
analysis (data not shown), the fact that they are small and 
cationic is demonstrated by their electrophoretic migration 
(Fig. 7), and their disappearance from acid-urea gels when 
treated with performic acid (which occurs with treatment of 
all defensins) indicates that they are eysteine-rich (Fig. 7 B). 
Taken together, these data suggest that cryptdin-related pep- 
tides may exist in the intestinal lumen, and that these pep- 
tides may be processed variants of the enteric defensins iso- 
lated from whole tissue. 
Conceivably, luminal cryptdin or cryptdin-like material 
could derive from exfoliated Paneth cells in the lumen, but 
the low rate of Paneth cell turnover suggests that is unlikely. 
Since lysozyme, another protein constituent of Paneth cell 
granules, is secreted into the lumen under cholinergic stimu- 
lation (Peeters and Vantrappen,  1975),  it is possible that 
similar stimuli are  responsible  for  secretion of intestinal 
defensins. The release of  cryptdins or processed variants into 
the small bowel by Paneth cells contrasts with the apparent 
lack of defensin secretion by leukocytes (Ganz, 1987),  and 
we propose that a secretory pathway may exist for the consti- 
tutive delivery of defensins into  the  intestinal  lumen by 
Paneth cells. 
Antimicrobial Activity of CrypMin-1 
The antibacterial activity of purified cryptdin-1,  the most 
abundant enteric defensin, was tested against wild-type and 
phoP mutant S. typhimurium  using a modified  plate diffusion 
assay  (Lehrer  et  al.,  1991b).  phoP  is  a  two-component 
regulatory locus that is essential to S. typhimurium  virulence 
and survival within maerophages (Fields et al., 1989; Miller 
et al., 1989), and mutants in the locus are particularly sensi- 
tive to rabbit defensins NP-1 and NP-2 when compared to 
wild-type parent strains (Fields et al.,  1989;  Miller et al., 
1990).  Under the assay conditions described (Material and 
Methods), the antimicrobial activity of rabbit defensin NP-1 
against wild-type and the phoP mutant organisms is quite 
similar (Fig. 8, lower panel). On the other hand, wild-type 
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cryptdin-1 at concentrations of the peptide that are effective 
against the attenuated mutant (Fig. 8, upper). The differen- 
tial activity of cryptdin-1  against avirulent S. typhimurium 
suggests that resistance to mueosal defensins may be of par- 
ticular importance for the evolution of virulence in enteric 
pathogens. 
Discussion 
Before the characterization  of a  mouse intestinal  defensin 
eDNA, expression of defensins was thought to be limited to 
professional phagocytes, i.e., neutrophils  and macrophages. 
The presence of high  levels of eryptdin mRNA in Paneth 
ceils led to the hypothesis that defensins synthesized in intes- 
tinal  epithelium  may  contribute  to  antimicrobial  barrier 
function  in the small bowel (Ouellette et al.,  1989a).  Our 
isolation  and characterization  of five eryptdin peptides and 
the demonstration of antibacterial  activity of the most abun- 
dant peptide, cryptdin-1, provides additional evidence for the 
antimicrobial  role of  defensins in the small intestine. The im- 
munohistochemieal  localization  of cryptdin(s)  to  Paneth 
cells is consistent with previous in situ hybridization  analy- 
sis, and suggests that defensins produced by these cells may 
act to limit bacterial colonization  and invasion of the small 
bowel. 
To establish  the epithelial  origin  of cryptdins  1-5,  we 
demonstrated their presence in sheets of intestinal  epithe- 
lium which were free of underlying lamina  propria.  Acid- 
urea PAGE analysis of epithelial  sheet extracts  showed that 
the five enteric defensins were present in approximately  the 
same relative quantities observed in the whole organ extracts 
(Fig. 5). The epithelial sheet preparations were judged to be 
devoid of stromal elements, because sheets prepared from 
21-d-old  mice  by  the  same  method  lack  class  II  anti- 
gen-associated invariant chain mRNA even though the lam- 
ina propria from the same mice is strongly positive for this 
mRNA (Sanderson et al.,  1992). 
To localize enteric defensins by immunohistologic meth- 
ods, an antibody was raised in rabbits immunized with a syn- 
thetic peptide containing  residues 4-35 of eryptdin-1, termed 
cryptdin-C (Materials and Methods). Correct folding and di- 
sulfide bond formation is essential to obtaining antibodies to 
natural  or synthetic defensins  (Selsted,  M. E., unpublished 
data). Similarly, only correctly folded and oxidized synthetic 
cryptdin-C was sufficiently  immunogertic to elicit IgG that 
was immunologically reactive with cryptdin-1  in an ELISA 
and in tissue sections; antibodies raised against linear crypt- 
din peptide fragments were immunologically unreactive.  As 
noted above, because cryptdins 1-3 are identical at 32 of 35 
residue positions, it is likely that the anti-cryptdin-C  anti- 
body reacts with all three peptides.  To date, Western immu- 
noblot analysis of individual eryptdins has not been possible, 
perhaps because the antibody-binding  epitope is masked or 
altered  by association  with the membrane matrix. 
Immunohistochemical analysis localized cryptdin antigen 
to the cytoplasm of Paneth cells of every crypt, and within 
these cells the staining was particularly strong over granules 
(Fig. 6 C). In addition,  cryptdin antigen appears to be pres- 
ent in the bowel lumen (Fig. 6). Though the immunoperoxi- 
dase "background"  appears increased in sections developed 
with anti-cryptdin-C  antibody,  the darker staining  is pre- 
dominantly  surface associated.  We suggest  that this may 
reflect the presence of cryptdin antigen coating the mucosal 
surface.  Based on  these  observations,  we speculate  that 
Paneth cells secrete defensins into the space above the crypt, 
where they may contribute to establishment of a local an- 
tibacterial  milieu.  This would be consistent with the ability 
of Paneth ceils to secrete lysozyme in response to eholiner- 
gic agents (Staley and Trier,  1965; Peeters and Vantrappen, 
1975; Satoh et al.,  1989). 
Peptides detected and partially purified from luminal  la- 
vage appear to be eryptdins that have been modified as com- 
pared to those isolated from intact tissue (Fig. 7). Possibly, 
the NH2-terminal extensions that characterize eryptdins 1-3 
undergo further processing in conjunction with their secre- 
tion.  Active secretion of intestinal  defensins  would distin- 
guish them from phagocyte defensins,  which are not nor- 
mally  secreted  and  appear  to  be primarily  targeted  for 
intracellular  delivery to the phagolysosome (Ganz,  1987). 
Experiments  are underway to determine whether mouse en- 
teric defensins are secreted in response to cholinergic  stim- 
uli, and the structural  relationships  of the tissue-extracted 
and luminal  forms. 
Enteric pathogens require the ability to resist mechanisms 
of mueosal immunity in order to cause disease.  S. typh/mu- 
rium is a  highly  virulent enteric pathogen of mice which 
causes typhoid fever. Strains  of S. typhimurium with muta- 
tions in the phoP locus, are avirulent and simultaneously ac- 
quire increased sensitivity to nentrophil  defensins (Fields et 
al,, 1989). This locus has been characterized as a two com- 
ponent regulatory system consisting of two genes, phoP and 
phoQ, which exert transcriptional  control over the synthesis 
of proteins  that  are  essential  to  virulence  (Miller,  1991; 
Miller  et al.,  1989;  Pullddnen  and  Miller,  1991). When 
cryptdin-1 was assayed for activity against the wild-type and 
phoP  mutant  strains  of S.  typhimurium,  dose-dependent 
clearing was observed against the mutant only, in contrast to 
the result with rabbit neutrophil  defensin NP-1 (Fig. 8). The 
susceptibility or resistance of isogenic Salmonella strains to 
Paneth cell antibacterial  peptides may provide a system for 
studying pathogen-host interactions  in vitro. S. typhimurium 
may have evolved virulence factors that allow  for survival 
and  invasion  in  an  intestinal  environment  rich  in  enteric 
defensins. 
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Note Added in Proof. A report summarizing an earlier method for purifica- 
tion and sequencing of cryptdin-1 was recently published (Ouellette, A. J., 
S. L Miller, A. H. Henschen,  and M. E. Selsted.  1992. Purification and 
primary structure of murine cryptdin-1, a Paneth cell defensin. FEBS/Fed. 
Fur. B/ochem. Soc.] Lett.  304:146-148). 
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